Corcept Therapeutics Ownership & Insider Activity

Corcept Therapeutics (CORT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 7.3% of shares outstanding. Institutional investors hold 39.1%. Over the past 90 days, insiders made 7 sales worth $17.0M.

Shares Outstanding

108.098M

Shares Float

83.903M

Insider Shares Owned

7.905M

Insider % Owned

7.3%

Institutional Shares Held

42.317M

Institutional % Held

39.1%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$17.0M total

Net Activity

Net Selling

Net Value (90d)

-$17.0M

Corcept Therapeutics Insider Transactions (Last 6 Months)

Ver todas las transacciones con información privilegiada →

Date	Insider	Title	Type	Shares	Price	Value
Oct 15, 2026	James N Wilson	—	SELL	10.000K	$114.81	$1.1M
Oct 2, 2026	Roberto Wandenkolk Vieira	PRESIDENT, ONCOLOGY	SELL-OPTIONS	—	$68.86	$787K
Oct 1, 2026	Joseph Douglas Lyon	SEE REMARKS	SELL-OPTIONS	—	$66.48	$992K
Oct 1, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$62.27	$2.7M
Sep 16, 2026	Roberto Wandenkolk Vieira	PRESIDENT, ONCOLOGY	SELL	296.000	$100.82	$30K
Sep 15, 2026	James N Wilson	—	SELL	10.000K	$110.69	$1.1M
Sep 14, 2026	Joseph Douglas Lyon	SEE REMARKS	SELL-OPTIONS	—	$63.24	$1.0M
Sep 1, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	183.000	$61.66	$2.7M
Sep 1, 2026	Roberto Wandenkolk Vieira	PRESIDENT, ONCOLOGY	SELL-OPTIONS	174.000	$66.30	$5.2M
Aug 26, 2026	Kimberly Park	—	SELL-OPTIONS	—	$67.99	$3.3M
Aug 25, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$68.46	$3.5M
Aug 18, 2026	David L Mahoney	—	SELL	103.606K	$118.25	$12.3M
Aug 17, 2026	Gary Charles Robb	CHIEF BUSINESS OFFICER	SELL	10.125K	$116.26	$1.2M
Aug 14, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$61.38	$389K
Aug 14, 2026	James N Wilson	—	SELL	10.000K	$111.43	$1.1M
Aug 10, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$61.39	$110K
Aug 10, 2026	William Guyer	CHIEF DEVELOPMENT OFFICER	SELL-OPTIONS	—	$67.54	$1.5M
Aug 4, 2026	William Guyer	CHIEF DEVELOPMENT OFFICER	SELL-OPTIONS	—	$67.39	$338K
Aug 3, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$61.49	$2.2M
Aug 3, 2026	Joseph Douglas Lyon	SEE REMARKS	SELL	1.540K	$114.16	$176K
Jul 30, 2026	Atabak Mokari	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$68.89	$7.3M
Jul 15, 2026	James N Wilson	—	SELL	10.000K	$88.30	$883K
Jul 15, 2026	Atabak Mokari	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$54.63	$2.6M
Jul 7, 2026	William Guyer	CHIEF DEVELOPMENT OFFICER	SELL-OPTIONS	—	$57.39	$1.4M
Jul 1, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$48.31	$2.0M
Jun 17, 2026	David L Mahoney	—	SELL	20.000K	$84.53	$1.7M
Jun 16, 2026	James N Wilson	—	SELL	10.000K	$83.20	$832K
Jun 15, 2026	Atabak Mokari	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$50.20	$2.5M
Jun 2, 2026	William Guyer	CHIEF DEVELOPMENT OFFICER	SELL-OPTIONS	—	$46.13	$979K
Jun 1, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	778.000	$39.99	$1.5M
Jun 1, 2026	Atabak Mokari	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	873.000	$45.03	$2.0M
May 29, 2026	Joseph K Belanoff	CHIEF EXECUTIVE OFFICER	SELL	12.837K	$69.74	$895K
May 27, 2026	Joseph Douglas Lyon	SEE REMARKS	SELL	5.000K	$65.00	$325K
May 27, 2026	Sean Maduck	SEE REMARKS	SELL-OPTIONS	—	$36.93	$4.3M
May 5, 2026	William Guyer	CHIEF DEVELOPMENT OFFICER	SELL-OPTIONS	—	$36.74	$604K
May 1, 2026	Joseph K Belanoff	CHIEF EXECUTIVE OFFICER	SELL	40.000K	$50.10	$2.0M

Corcept Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Corcept Therapeutics Ownership & Insider Activity

Corcept Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch